1 |
Androgen deprivation (ADT)/adjuvant hormonal therapy for high-risk prostate cancer patients |
15 |
2 |
Clinical T stage documented |
10 |
2 |
Avoidance of overuse measure—bone scan for staging low-risk patients |
10 |
3 |
PSA level documented |
9 |
3 |
Gleason score reported to patient |
9 |
3 |
Treatment options counseling (multidisciplinary) |
9 |
4 |
Following up with the patient at least twice during the first year after treatment |
7 |
5 |
Comorbidity assessment |
6 |
5 |
The proportion of patients treated by a high-volume (upper tertile) provider (surgeon or radiation oncologist) |
6 |
6 |
Radical prostatectomy pathology reporting |
4 |